# VIVJOA

NDC: 74695-823
Generic name: oteseconazole
Labeler / Manufacturer: Mycovia Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20220711

FDA application: NDA215888

## Active ingredients

- OTESECONAZOLE: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"74695-823"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=74695-823
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e21d5008-800e-4417-927f-14340341865f